CHRS Operating Cash Flow (Statement)
Coherus Oncology Inc · Operating Cash Flow (Statement)
CHRS Operating Cash Flow (Statement)
Latest reported-$243.92Mperiod ending
CHRS Cash from Operations (-$18.25M → -$243.92M)
Annual operating cash flow (statement)
High-resolution chart · PNG
CHRS operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -138,513,000 | |
| -20,440,000 | |
| -174,884,000 | |
| -241,124,000 | |
| -37,432,000 | |
| 154,145,000 | |
| 28,355,000 | |
| -159,266,000 | |
| -200,286,000 | |
| -252,545,000 | |
| -107,990,000 | |
| -23,927,000 | |
| 15,423,000 | |
| -18,251,000 |